PMID- 36012625 OWN - NLM STAT- MEDLINE DCOM- 20221227 LR - 20221227 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 23 IP - 16 DP - 2022 Aug 19 TI - SEPT9 Upregulation in Satellite Glial Cells Associated with Diabetic Polyneuropathy in a Type 2 Diabetes-like Rat Model. LID - 10.3390/ijms23169372 [doi] LID - 9372 AB - Despite the worldwide prevalence and severe complications of type 2 diabetes mellitus (T2DM), the pathophysiological mechanisms underlying the development of diabetic polyneuropathy (DPN) are poorly understood. Beyond strict control of glucose levels, clinical trials for reversing DPN have largely failed. Therefore, understanding the pathophysiological and molecular mechanisms underlying DPN is crucial. Accordingly, this study explored biochemical and neuropathological deficits in a rat model of T2DM induced through high-fat diet (HFD) feeding along with two low-dose streptozotocin (STZ) injections; the deficits were explored through serum lipid, neurobehavioral, neurophysiology, neuropathology, and immunohistochemistry examinations. Our HFD/STZ protocol induced (1) mechanical hyperalgesia and depression-like behaviors, (2) loss of intraepidermal nerve fibers (IENFs) and reduced axonal diameters in sural nerves, and (3) decreased compound muscle action potential. In addition to hyperglycemia, which was correlated with the degree of mechanical hyperalgesia and loss of IENFs, we observed that hypertriglyceridemia was the most dominant deficit in the lipid profiles of the diabetic rats. In particular, SEPT9, the fourth component of the cytoskeleton, increased in the satellite glial cells (SGCs) of the dorsal root ganglia (DRG) in the T2DM-like rats. The number of SEPT9(+) SGCs/DRG was correlated with serum glucose levels and mechanical thresholds. Our findings indicate the putative molecular mechanism underlying DPN, which presumably involves the interaction of SGCs and DRG neurons; nevertheless, further functional research is warranted to clarify the role of SEPT9 in DPN. FAU - Kan, Hung-Wei AU - Kan HW AD - School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan. FAU - Ho, Yu-Cheng AU - Ho YC AD - School of Medicine, College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan. FAU - Chang, Ying-Shuang AU - Chang YS AD - Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. FAU - Hsieh, Yu-Lin AU - Hsieh YL AUID- ORCID: 0000-0002-6380-3455 AD - Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. AD - School of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. AD - Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan. LA - eng PT - Journal Article DEP - 20220819 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - IY9XDZ35W2 (Glucose) RN - 0 (Lipids) RN - 0 (Septin9 protein, rat) RN - EC 3.6.1.- (Septins) RN - 5W494URQ81 (Streptozocin) SB - IM MH - Animals MH - Rats MH - *Diabetes Mellitus, Experimental/pathology MH - *Diabetes Mellitus, Type 2/pathology MH - *Diabetic Neuropathies/pathology MH - Ganglia, Spinal/pathology MH - Glucose/therapeutic use MH - Hyperalgesia MH - Lipids/therapeutic use MH - *Neuralgia/pathology MH - Neuroglia/pathology MH - Rats, Sprague-Dawley MH - *Septins/genetics MH - Streptozocin MH - Up-Regulation PMC - PMC9409324 OTO - NOTNLM OT - diabetic polyneuropathy OT - hypertriglyceridemia OT - neuropathic pain OT - satellite glial cell OT - septin-9 COIS- The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. EDAT- 2022/08/27 06:00 MHDA- 2022/08/30 06:00 PMCR- 2022/08/19 CRDT- 2022/08/26 01:24 PHST- 2022/07/31 00:00 [received] PHST- 2022/08/16 00:00 [revised] PHST- 2022/08/18 00:00 [accepted] PHST- 2022/08/26 01:24 [entrez] PHST- 2022/08/27 06:00 [pubmed] PHST- 2022/08/30 06:00 [medline] PHST- 2022/08/19 00:00 [pmc-release] AID - ijms23169372 [pii] AID - ijms-23-09372 [pii] AID - 10.3390/ijms23169372 [doi] PST - epublish SO - Int J Mol Sci. 2022 Aug 19;23(16):9372. doi: 10.3390/ijms23169372.